A phase I study of thymoglobulin [antithymocyte globulin] in patients with relapsed or refractory multiple myeloma

Trial Profile

A phase I study of thymoglobulin [antithymocyte globulin] in patients with relapsed or refractory multiple myeloma

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Antithymocyte globulin (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Jul 2008 The expected completion date has been changed from 1 Jun 2009 to 1 Jul 2008 (information from ClincialTrials.gov).
    • 31 Jul 2008 Status changed from recruiting to completed based on information from ClinicalTrials.gov.
    • 27 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top